In Vitro Diagnostics Market worth $75.1 Billion By 2020

1
MarketsandMarkets Presents
In Vitro Diagnostics Market worth 69.1 Billion
By 2020
2

• The In Vitro Diagnostic (IVD) Market
  Instruments, Reagents Data Management Systems
  Technique (Immunoassay, Clinical Chemistry,
  Molecular Diagnostics, Haematology)
  Applications (Diabetes, Infectious Diseases,
  Cancer Cardiology) Systems, End Users
  Forecast To 2017 analyzes and studies the major
  market drivers, restraints, and opportunities in
  Americas, Europe, Japan, BRIC and Rest of the
  World.
• Browse 178 market data tables and 50 figures
  spread through 421 pages and in-depth TOC on In
  Vitro Diagnostic (IVD) Market Instruments,
  Reagents Data Management Systems Technique
  (Immunoassay, Clinical Chemistry, Molecular
  Diagnostics, Haematology) Applications
  (Diabetes, Infectious Diseases, Cancer
  Cardiology) Systems, End Users Forecast to
  2020.
• http//www.marketsandmarkets.com/Market-Reports/iv
  d-in-vitro-diagnostics-market-703.html

3

Early buyers will receive 10 customization on
Reports.
4

• This report studies the global in vitro
  diagnostics (IVD) market, with forecast to 2017.
  The IVD market studied in this report has been
  segmented on the basis of technology, product
  type, application, end-user, and geography. The
  global IVD market valued at 49.2 billion in 2012
  is primarily driven by rising incidences of
  chronic and infectious diseases in emerging
  economies, a rapidly aging population, the rise
  in point-of-care testing, the rising importance
  of personalized medicine, ongoing developments in
  analytical laboratory automation and finally,
  the geographical market expansion within emerging
  countries. However, factors such as stringent
  regulatory frameworks and a shortage of budget
  and labor are restraining the growth of the
  market.
• In 2012, the Americas had accounted for the
  largest share of 41.8 in 2012 of the global IVD
  market. Europe was the second largest-market with
  the share of 31.0 in 2012. However, the BRIC
  countries represent the fastest-growing markets
  due to the economic growth, the rising number of
  chronic diseases, and an increasing awareness
  about the use of IVD tests to control the spread
  of diseases.

5

• Moreover, the economic slowdown, pricing
  pressures, and high competition in mature
  countries will compel companies to focus on
  emerging markets.
• Abbott Laboratories, Inc. (U.S.), Roche
  Diagnostics Limited (Switzerland), Becton,
  Dickson and Company (U.S.), Siemens Healthcare
  (Germany), Diagnostica Stago SAS (France),
  Danaher Corporation (U.S.), Thermo Fisher
  Scientific, Inc. (U.S.), ARKRAY, Inc. (Japan),
  Bio-Rad Laboratories, Inc. (U.S.), DiaSorin
  S.p.A. (Italy), Sysmex Corporation (Japan),
  bioMérieux (France), HORIBA, Ltd. (Japan), and
  Alere, Inc. (U.S.) are the leading players in the
  global IVD market.

6
About MarketsandMarkets
Markets and Markets is a global market research
and consulting company based in the U.S. We
publish strategically analyzed market research
reports and serve as a business intelligence
partner to Fortune 500 companies across the
world. Markets and Markets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotive and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at Markets and
Markets are inspired to help our clients grow by
providing apt business insight with our huge
market intelligence repository.
7
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Blog http//twitter.com/marke
tsmarkets
http//www.linkedin.com/company/marketsandmarkets